ABSTRACT Background X-linked hypohidrotic ectodermal dysplasia (XLHED), the most common type of ectodermal dysplasia, is caused by EDA gene mutations. Reduced sweating contributes substantially to XLHED associated morbidity and mortality. To characterise the genotypeephenotype relationship, sweat gland function was assessed non-invasively in XLHED patients and healthy controls. Subjects and methods In 36 genotyped XLHED patients and 29 control subjects aged 0e57 years, pilocarpine-induced sweat volume, palmar sweat pore density, and palmar skin conductance before and after stimulation were determined.
INTRODUCTION
X-linked hypohidrotic ectodermal dysplasia (XLHED (MIM 305100)), the most common type of ectodermal dysplasia, is characterised by severe hypohidrosis, hypoplasia of sweat, sebaceous, submucous, meibomian and mammary glands, sparse hair and eyebrows, and oligodontia. The disease is caused by EDA (MIM 300451) gene mutations. Reduced sweating is assumed to be a major contributor to XLHED-associated morbidity and mortality. 1 The EDA gene spans approximately 425 kb of genomic sequence on the human X chromosome and encodes ectodysplasin A, a trimeric type II transmembrane protein belonging to the tumour necrosis factor (TNF) superfamily of ligands. Eight transcriptional variants due to alternative splicing are known. The longest transcript consists of exons 1a, 3a, and 4e9 (nomenclature according to Bayés , encoding the 391 amino acids of the ectodysplasin A1 isoform (EDA-A1), lack of which has been demonstrated to underly XLHED. EDA-A1 comprises a small N-terminal intracellular, a transmembrane, and a large C-terminal extracellular domain with a furine cleavage site, a collagen-like domain consisting of 19 Gly-X-Y repeats with a single interruption, and a TNF homology domain. To be able to bind to its receptor EDAR, EDA-A1 has to be released by proteolytic processing at the furin recognition site as a soluble homotrimerised protein consisting of the collagen-like and TNF homology domains. Further multimerisation through the collagen-like region has been shown 4 and seems to be important for protein function.
The phenotype of individuals affected by XLHED shows interfamilial as well as intrafamilial variability, and no clear genotypeephenotype correlation has been observed so far. 5e8 However, at least six EDA missense mutations causing a specific phenotype of non-syndromic selective tooth agenesis have been described. 4 9e13 Thus, one may hypothesise that the occurrence or severity of particular XLHEDrelated symptoms might correlate with the EDA genotype. Our present study, therefore, aimed at establishing quantitative skin assessment techniques to evaluate a genotypeephenotype relationship with respect to sweating ability.
SUBJECTS AND METHODS
Thirty-one male XLHED patients aged from 0 to 57 years and 24 healthy, age-matched male controls with no family history of XLHED or negative testing for an EDA mutation, as well as five heterozygous females and five healthy female controls, were studied. All adults gave written informed consent to participate; in the case of minors, parental consent and child assent in >7-year-olds was obtained. The study (http:// clinicaltrials.gov/ NCT01109290) was approved by an independent institutional ethics committee and conducted according to national regulations and GCP/ICH (Good Clinical Practice/International Conference on Harmonisation) guidelines.
XLHED patients were included only if pathogenic EDA mutations had been detected and liquid intake on the day of the study had been normal. Criteria for exclusion were acute febrile illness, implantable electronic devices, pregnancy or breastfeeding, and hypersensitivity to selfadhesive electrodes. Subjects were studied either at a GermaneAustrian bi-national family conference in Germany in May 2010 or during an appointment at the Competence Centre for Children with Ectodermal Dysplasias of the University Hospital Erlangen between May and August 2010. Subjects ED-Ch1 and ED-AS4, EDCh2 and ED-AS5, and ED-Ch11 and ED-AS7, respectively, have documented familiar relationships.
Medical and dental history was taken using a specific questionnaire, interviews, and orthodontic records of permanent dentition. Parameters determined included palmar sweat pore density in an area of 16 mm 2 , sweat volume produced in a 30 min period subsequent to stimulation with pilocarpine using the Wescor 3700 device (Wescor Biomedical Systems, Logan, USA), and palmar skin conductance, an indirect measure of skin hydration, 14 taken with the Med-Storm 1001 device (Med-Storm, Oslo, Norway). The examiners were blinded to the genotype of the participant.
First, standard sweat collection was conducted at the forearm site, as an even surface area of 57 mm 2 was needed. Maximum volume that could be collected in the Wescor device was 93 ml (estimated by weight). Then, sweat pore density was determined on graphite prints of the palm, which had been enlarged 16-fold, and calculated per cm 2 . Finally, palmar skin conductance measurements were recorded at baseline and following capillary blood sampling.
For genotyping, DNA was extracted from peripheral blood or buccal swabs (OmniSwab, Whatman International Ltd., UK) using standard procedures or following manufacturer 's instructions, respectively. PCR was performed with specific primer pairs for exons 1a, 3a, and 4e9 selected with Primer3 and checked with MFOLD and SNPCheck. The PCR products were treated with ExoSAP-IT (USB Corporation, Cleveland, Ohio, USA) according to the manufacturer 's instructions, and sequenced using the BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Carlsbad, California, USA) and a 3730 DNA Analyser (Applied Biosystems). Screening for larger deletions/duplications was done by multiplex ligation-dependent probe amplification (MLPA; MRC-Holland_P183, Netherlands) according to the manufacturer 's instructions. To validate that any previously unreported nucleotide substitutions are real mutations, at least 100 healthy, anonymised, population-matched males were tested for each alteration by EDA sequence analysis.
Group comparisons, both between affected and control subjects and between adult and paediatric subsets, were done by ManneWhitney and exact Fisher 's tests using GraphPadPrism software version 4.0 for Windows (GraphPad Software, Inc, La Jolla, California, USA) or SPSS software version 17.0 for Windows (SPSS Inc).
RESULTS

Assessment and quantification of sweat gland function
As perspiration may change with puberty, which had also been observed in one of our previous studies on ectodermal dysplasia, 15 the XLHED cohort and the controls were divided into groups of children and postpubertal individuals (adults) with a cut-off of 16 years.
Individual data for each subject tested are shown in tables 1 and 2. As expected, control children had a significantly higher density of sweat pores than control adults (p<0.001), which is explained by the smaller body surface area of the children. However, control adults produced larger sweat volumes than control children (p¼0.0014). When stimulated by pilocarpine, sweat glands of children did not equal the function of adult sweat glands, but seem to reach maturity with puberty.
One of the XLHED patients, ED-AS1, reported that despite being unable to sweat as a child, he had realised some sweating for the first time during puberty with further improvement thereafter and got to know a few regions of his body, including the margins of both palms, where he can sweat. However, XLHED children and adults did not differ in sweat volume, basal or stimulated skin conductance. Therefore, age groups were pooled where appropriate for further comparisons of XLHED and control subjects.
Control subjects had 455 sweat pores/cm 2 on average (range 294e900), which varied by age as expected, and a mean sweat volume of 72 ml following stimulation (range 29e93 ml). There was a clear demarcation between the XLHED males and controls across all measurements of sweat gland function (p<0.0001), that was less consistent in the females studied (table 3) . However, in seven of 31 male adults and all female adults with XLHED some sweat was detectable by the Wescor assay. Dermatoglyphic investigation of the graphite prints revealed the complete absence or a significant lack of sweat pores and partial ridge dissociation in the 24 male XLHED patients who were unable to sweat (figure 1). Palmar skin conductance measurements in these 24 males typically showed both low baseline values and the absence of conductance increase (equivalent to absence of sweat gland function) following capillary blood sampling, whereas in control subjects a transient rise in palmar skin conductance indicated pain-inducible sweat gland function (figure 1). Among XLHED males (tables 1 and 2), 14/31 had neither detectable sweat pores nor inducible sweating, 15/31 showed a few sweat pores (6e113 cm 2 ) correlating with absence of sweat or low sweat volumes (up to 11.0 ml), and 2/31 had normal sweat pore counts but notably reduced pilocarpinestimulated sweat volumes. In general, the number of sweat pores at the palm did not correlate with the ability to sweat. Although no adult male XLHED subject had more than 10 permanent teeth, there was also no correlation between the number of missing teeth and sweat production.
Basal skin conductance, an indirect measure of skin hydration, was reduced (<20.0 mS) in 23 of 24 non-sweating as well as in two of seven low-sweating XLHED males and in one of five XLHED females, but none of the controls. In healthy subjects, baseline values were lowest in the neonate and two adults known to have dry skin. Similarly, stimulated skin conductance following blood sampling was reduced (<7.0 mS) in 23 of 24 non-sweating XLHED males, two of seven with decreased sweating, one of five XLHED females, but only one of 28 controls. Typically, a relatively broad peak was observed within 2 s after the needle stick associated with capillary blood draw, the maximum of which was taken for the calculation of conductance increase. However, the pain threshold differed remarkably among individuals. The largest increase was observed in the control children, whereas athletic, tall men showed the weakest reaction. Despite large interindividual differences, the skin conductance measurements were reproducible and well tolerated by both age groups. This non-invasive technology, validated for use in newborns, 16 provided evidence of lack of sweat gland function even in a neonate (subject EDCh11) with a known family history of XLHED.
Genotypeephenotype correlations
Sequence analysis of the EDA gene in our XLHED cohort revealed a total of 26 different EDA mutations, 11 of which are known from the literature 2e4 7 8 17e19 while 15 have not yet been described (tables 1e3). None of the missense or splice site mutations was present in a control group of 100 healthy males.
The 25 mutations detected in male XLHED subjects (figure 2) included 15 mutations expected to cause pronounced impairment of ectodysplasin A synthesis or release. All patients carrying gross deletions (exon 1, exon 3 or exons 4e9), small out-of-frame deletions (Pro17GlyfsX81, Thr278LeufsX2) or a nonsense mutation (W274X) were anhidrotic. Four EDA mutations altering a splice acceptor (c.527G/T, c.707-2A/G, c.707-2A/T) or splice donor site (c.793+1G/C) were identified, three of which also led to a severe phenotype without any sweating ability (subjects ED-A6, ED-A8, ED-A10). In addition, two small in-frame deletions detected in exon 5 (P220_P225del) and exon 9 (N372_S374del) were associated with anhidrosis. Among the 12 missense mutations found in this study, three are known to abolish furin cleavage (R153C, R155C, R156H). These mutations were discovered in non-sweating patients only.
The mutation G291R provided an unexpected example for clear genotypeephenotype correlation; all subjects with this mutation were unable to sweat under test conditions. Moreover, anhidrosis was caused by the mutation G2C within the intracellular domain of ectodysplasin A, by mutations G215R and G224V affecting its collagen triple helix, and by mutation Y304C within the TNF homology domain (figure 2).
On the other hand, all individuals with the missense mutations V262F, R276C or G299R, which are also situated in the TNF homology domain (figure 2), showed some residual sweating ability. Another missense mutation outside of a known functional domain (R69L) was associated with moderately reduced sweat gland function and a mild phenotype in general (short stature and low body weight, but dark hair, normal teeth, and a face indistinguishable from healthy children).
Interestingly, a small in-frame deletion in exon 5 (N185_ P196del) was detected in subject ED-AS1 who was able to produce some sweat. xExcluding third molars and extracted teeth.
DISCUSSION
This study demonstrates that sweat collection following pilocarpine iontophoresis on the forearm can discriminate clearly between XLHED males and healthy controls. The sweat pore count also delineated affected males with high sensitivity (94% for children, 92% for adults), whereas skin conductance was less definitive as a diagnostic parameter. Such conductance measurements appear useful as a paediatric screening tool, but have reduced sensitivity in detecting XLHED patients with residual sweat gland function.
Furthermore, the study identified deleterious mutations of the EDA gene resulting in most severe sweat gland dysfunction, whereas other mutations were found to be associated with residual sweating ability.
Sweating could not be induced in any male XLHED subject with an exon deletion, small out-of-frame deletion or nonsense mutation in EDA, for all of which premature termination of translation was predicted. Moreover, missense mutations affecting the furin recognition site of ectodysplasin A consistently resulted in anhidrosis. The altered protein sequence at Arg 153 , Arg 155 or Arg 156 disrupts this recognition site and prevents proteolytic processing and release of the soluble ligand. 20 Two other functionally crucial missense mutations (Gly291Arg, Tyr304Cys) and an in-frame deletion (N372_S374del) were identified within the TNF homology domain. As the impact of various mutations on protein structure and receptor binding capacity has been shown in vitro to differ significantly, 4 it is noteworthy that all three subjects carrying the mutation Gly291Arg hemizygously were anhidrotic, suggesting that the affected amino acid may be essential for proper protein folding as already hypothesised. 4 A severe phenotype without any sweating ability would also be expected in all four males with splice site mutations in exon 5 of EDA predicted to abolish the regular splice site using the BDGP splice site prediction tool (referenced at the end). Such mutations commonly result in an aberrant, non-functional protein due to out-of-frame exon skipping or use of alternative splice sites, respectively. However, only three of these four patients showed a severe phenotype. Surprisingly, subject ED-ChS5 who carries the putative splice site mutation c.527G/T was able to sweat. In this patient, two of the predicted alternative splice sites within exon 5, which codes mainly for the collagen-like domain, revealed a high acceptor score of 0.67 and 0.83 and would result in an in-frame deletion of three or 13 of the 19 Gly-X-Y repeats, respectively. Although this may explain the milder phenotype seen in this patient, prediction of phenotypic consequences of in-frame deletions within the collagen-like domain seems particularly difficult. FLAGtagged recombinant EDA-A1 without the collagen domain (EDA-A1 E245) as well as a deletion mutant lacking four of the 19 Gly-X-Y repeats (EDA-A1 S160 Δ185e196) have been shown to bind to EDAR equally well in vitro, and the latter also did not affect multimerisation. 4 In line with this observation, patient ED-AS1 had a normal number of sweat pores and was able to produce some sweat. In contrast, multimerisation was not observed in vitro if the first half of the collagen domain was deleted (in frame), suggesting that certain mutations have specific impact on multimerisation. 4 This may provide an explanation for the different findings in subject ED-Ch1 with a small in-frame deletion within the collagen domain as well as for two of our non-sweating patients (ED-Ch3, ED-Ch9) who carry missense mutations altering glycine residues, which leads to an additional interruption of the Gly-X-Y repeats and might disturb protein tri-or multimerisation due to reduced solidity of the collagen helix. 3 In patients with the missense mutations Val262Phe, Arg276Cys or Gly299Arg in the TNF homology domain, sweat gland function was affected only moderately. Although one of these mutations (Gly299Arg) is located within the most homologous motif of TNF ligands (Leu 293 -Val 309 ), 21 a residual, probably tissue-specific receptor binding activity cannot be excluded and has already been demonstrated for other mutations within the TNF homology domain. 13 The missense mutation Arg69Leu, situated outside of a known functional domain but close to the extracellular end of the transmembrane domain, led to a mild phenotype including some sweating ability which may, however, not be sufficient to preclude overheating. This mutation may reduce expression or translocation, and therefore dosage, of otherwise normal ligand, as proposed for two similar mutations (Arg65Gly, 22 Glu67Val 12 ) associated with an oligosymptomatic phenotype (hypodontia). 13 However, the mutation Arg69Leu was also detected in patients with apparently typical XLHED, 4 7 19 making the prediction of its phenotypic consequences rather difficult.
In conclusion, we have shown that within the EDA gene gross deletions, splice site mutations expected to lead to exon skipping or use of alternative splice sites, nonsense mutations, missense mutations altering furin cleavage as well as mutations affecting specific amino acids of ectodysplasin-A (eg, glycine residues within the Gly-X-Y repeats or Gly 291 ) are associated with severely compromised sweat gland function, which is a major determinant of XLHED-associated morbidity and mortality. Genotypeephenotype correlation was seen across all measurements of sweat gland function, but, surprisingly, not with respect to the number of sweat glands (which can be determined very soon after birth) and the degree of oligodontia (diagnosable already by prenatal ultrasonography). This is important since such easily recognisable signs obviously do not allow prediction of the risk of hyperthermia and the associated morbidity and mortality in XLHED patients. Our results imply that systematic mapping of EDA mutations together with the analysis of objective clinical data may help to distinguish functionally crucial mutations from those allowing residual, possibly tissue-specific activity of the EDA-A1 protein.
Furthermore, these data might be useful to improve our understanding of ectodysplasin A function and signalling and to identify putative sites of interaction with other proteins.
